Western blot analysis was performed to assess the levels of Cleaved-Caspase-3 and Cleaved-Caspase-9 both in vivo and in vitro, and the results showed that fosinopril effectively promoted the activation of both Caspase-3 and Caspase-9 in NSCLC. Here, CASP3 is linked to non-small cell lung carcinoma.